Discover 604 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lincoln offers a wide variety of trials focused on numerous chronic conditions like diabetes, mental health disorders, and cardiovascular diseases. Participants, including healthy volunteers seeking paid research opportunities or those with a particular health condition, can explore new treatment options while contributing to the development of groundbreaking therapies.
Filter
2
Filter results
Results: 604
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Lincoln NE, Tulsa OK, Lone Tree CO, Lafayette CO,
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: Lincoln NE, Omaha NE, Papillion NE, Council Bluffs IA,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT05806515
Phase2, Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
for
Solid Tumors
Location: Lincoln NE, Wheat Ridge CO, Anderson TX, Houston TX,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06953089
Phase2, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Lincoln NE, Kansas City KS, Peoria IL, Madison WI,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase2, Phase3, Recruiting
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Lincoln NE, Dallas TX, Detroit MI, Houston TX,
Sponsor: Zydus Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07023835
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Lincoln NE, Sioux City IA, Kansas City MO,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase2, Phase3, Recruiting
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Lincoln NE, Omaha NE, Kansas City KS, Rochester MN,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT07143669
Recruiting
Study of COYA 302 for the Treatment of ALS
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Lincoln NE, St Louis MO, Chicago IL, Dallas TX,
Sponsor: Coya Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07161999
Phase2, Phase3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Lincoln NE, Chaska MN, Burnsville MN, Edina MN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Lincoln NE, Dallas TX, Nashville TN, Billings MT,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase2, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Lincoln NE, Westwood KS, Des Moines IA, Aurora CO,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
for
Solid Tumor
Location: Lincoln NE, Nashville TN, San Antonio TX, Orlando FL
Sponsor: Corbus Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06603844
Phase1, Phase2, Recruiting
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
for
Extensive-stage Small-cell Lung Cancer
Location: Lincoln NE, Ames IA, Cedar Rapids IA, St Louis MO,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712355
Phase3, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Lincoln NE, Kansas City KS, Bridgeton MO,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase3, Recruiting
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: Lincoln NE, Houston TX, Baton Rouge LA, El Paso TX,
Sponsor: Stichting European Myeloma Network
Sex: All
Age: 18+
Code: NCT05028348
Phase3, Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Lincoln NE, Omaha NE, Des Moines IA, Sioux Falls SD,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Lincoln NE, Columbia MO, Littleton CO, Chicago Ridge IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase2, Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostatic Neoplasms, Castration-Resistant
Location: Lincoln NE, Sioux Falls SD, Wichita KS, Watertown SD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07225946
Phase3, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Lincoln NE, St Louis MO, O'Fallon IL, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Lincoln NE, Omaha NE, Waukee IA, Iowa City IA,